ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Disruption Of Operations At The Company'S Manufacturing Facilities At Sikkim Due To Flash Floods.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

930.6500 13.95 (1.52%)

NSE Oct 08, 2025 15:31 PM

28.63% Fall from 52W High

Volume: 92,156

Alembic Pharmaceuticals Ltd.

04 Oct 2023

930.65

1.52%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please find enclosed the intimation for disruption of operation at the Company''s manufacturing Facility at Sikkim due to flash flood

More from Alembic Pharmaceuticals Ltd.

Recommended

Market closes lower, Tilaknagar Ind gets CCI nod to acquire Imperial Blue for Rs 4,150 cr

Trendlyne Marketwatch | 08 Oct 2025, 04:07PM

Five stocks to buy from analysts this week - October 7, 2025

The Baseline | 07 Oct 2025, 04:28PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals